Kellanova Stock Forecast for 2023 - 2025 - 2030
Updated on 04/22/2024
Kellanova Stock Forecast and Price Target
The average target price set lately by ten experts for Kellanova to reach by the end of the year is $60.00, which would imply a potential upside of approximately 3.48 percent from the previous closing price if it were to be achieved. This prediction is based on a high estimate of $75.00 and a low estimate of $55.00. Even if you are not interested in K stock, you should be aware of its competitors and their current standings.
3.48% Upside
Kellanova Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Kellanova's Price has fallen from $63.96 to $0.00 – a 100.00% decrease. For the next year, analysts predict that Fair Value will reach $71.49 – an increase of 100.00%. Over the next seven years, experts believe that Kellanova's Fair Value will grow at a rate of 100.00%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
NESN Stock Forecast | Nestlé | Outperform |
11
|
CHF93.84 | Buy/Sell | CHF115.58 | 17.22% |
KO Stock Forecast | Coca Cola | Outperform |
18
|
$60.55 | Buy/Sell | $65.84 | 9.00% |
OR Stock Forecast | L'Oréal | Hold |
18
|
441.00€ | Buy/Sell | 419.40€ | 2.04% |
PEP Stock Forecast | PepsiCo | Outperform |
18
|
$176.46 | Buy/Sell | $187.26 | 4.84% |
ABT Stock Forecast | Abbott Laboratories | Outperform |
9
|
$107.07 | Buy/Sell | $118.92 | 18.61% |
Kellanova Revenue Forecast for 2023 - 2025 - 2030
In the last two years, Kellanova's Revenue has fallen from $14.18B to $13.12B – a 7.47% decrease. For the next year, analysts predict that Revenue will reach $14.94B – an increase of 13.87%. Over the next seven years, experts believe that Kellanova's Revenue will grow at a rate of 39.93%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
ULVR Stock Forecast | Unilever PLC | Hold |
8
|
£38.85 | Buy/Sell | £50.61 | 27.82% |
MDLZ Stock Forecast | Mondelez International | Buy |
15
|
$69.41 | Buy/Sell | $83.21 | 18.14% |
DGE Stock Forecast | Diageo | Hold |
13
|
£28.57 | Buy/Sell | £30.63 | 33.04% |
Kellanova Dividend per Share Forecast for 2023 - 2025 - 2030
In the last two years, Kellanova's Dividend per Share has grown, moving from $2.31 to $2.34 – an increase of 1.30%. In the next year, analysts predict that Dividend per Share will jump to $2.52 – up 7.69% from the current level. Looking ahead to seven years, experts forecast that Dividend per Share will grow by 61.97%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
MO Stock Forecast | Altria Group Inc | Hold |
5
|
$42.57 | Buy/Sell | $46.90 | 5.71% |
CL Stock Forecast | Colgate-Palmolive Co | Outperform |
18
|
$88.33 | Buy/Sell | $88.97 | 5.29% |
500696 Stock Forecast | Hindustan Unilever | Outperform |
10
|
Rp2.24k | Buy/Sell | Rp2.75k | 21.31% |
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
EL Stock Forecast | Estee Lauder Cos Inc-The | Outperform |
18
|
$147.42 | Buy/Sell | $138.34 | 7.45% |
KHC Stock Forecast | Kraft Heinz | Outperform |
12
|
$38.15 | Buy/Sell | $40.16 | 6.16% |
KMB Stock Forecast | Kimberly-Clark | Hold |
18
|
$128.93 | Buy/Sell | $128.04 | 3.93% |
Kellanova EBITDA Forecast for 2023 - 2025 - 2030
In the last two years, Kellanova's EBITDA has gone down from $2.43B to $1.82B – a 25.13% drop. In the next year, analysts believe that EBITDA will reach $2.44B – an increase of 34.06%. For the next seven years, the forecast is forEBITDA to grow by 95.22%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
GIVN Stock Forecast | Givaudan | Hold |
14
|
CHF3.95k | Buy/Sell | CHF3.14k | -2.41% |
GIS Stock Forecast | General Mills Inc | Hold |
18
|
$71.17 | Buy/Sell | $68.63 | 1.17% |
HSY Stock Forecast | Hershey Co-The | Hold |
14
|
$186.33 | Buy/Sell | $211.72 | 11.63% |
Kellanova EBIT Forecast for 2023 - 2025 - 2030
In the last two years, Kellanova's EBIT has fallen from $1.96B to $1.40B – a 28.67% decrease. In the coming year, analysts are expecting an increase in EBIT, predicting it will reach $1.92B – an increase of 36.71%. Over the next seven years, experts anticipate that EBIT growth for Kellanova will be 107.71%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
RKT Stock Forecast | Reckitt Benckiser Group | Outperform |
12
|
£42.66 | Buy/Sell | £66.68 | 34.79% |
BEI Stock Forecast | Beiersdorf | Outperform |
17
|
136.40€ | Buy/Sell | 137.41€ | 9.24% |
ADM Stock Forecast | Archer-Daniels-Midland | Hold |
8
|
$62.50 | Buy/Sell | $67.70 | 1.92% |
Kellanova EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Kellanova's EPS has fallen from $3.99 to $0.00 – a 100.00% decrease. For the next year, analysts predict that EPS will reach $4.46 – an increase of 100.00%. Over the next seven years, experts believe that Kellanova's EPS will grow at a rate of 100.00%.
Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
---|---|---|---|---|---|---|---|
HEN3 Stock Forecast | Henkel AG & Co. KGaA | Hold |
16
|
74.04€ | Buy/Sell | 71.63€ | 1.30% |
LISN Stock Forecast | Hold |
3
|
CHF102.80k | Buy/Sell | CHF103.73k | 7.00% | |
NZYM B Stock Forecast | Novozymes A/S | Outperform |
18
|
kr385.00 | Buy/Sell | kr365.54 | 12.99% |